[ad_1]
Panorama
Many people in Germany, according to a press article in 2017 alone, have taken valsartan, a medicine that has been given a potentially carcinogenic substance. We do not know what long-term consequences this could have. What should patients do now?
Up to 900,000 patients nationwide, according to a newspaper article, could have taken blood pressure alone the previous year who was contaminated with a potentially carcinogenic substance. This comes out of a federal government response to a request from the Greens, which was the "Tagesspiegel" of Berlin. The antihypertensive drugs concerned are drugs containing the active substance valsartan. In early July, regulators in Europe ordered a stop of sales and a preventive recall for many of these drugs.
In 2017, about nine million packets of drugs containing valsartan were prescribed at the expense of public health insurance, Sabine Weiss said. Tagesspiegel "with." As about 40% of batches are affected by the recall, about 900,000 patients may be affected by the above mentioned prescriptions. "However, in the opinion of the European Medicines Agency (EMA) "no acute risk to health."
The Greens in the Bundestag have criticized the way the authorities are dealing with the issue: The EMA's statement quiet little, says the group's pharmaceutical expert , Kordula Schulz, the newspaper.Finally, the drugs were contaminated for six years and the long-term use risks could only be evaluated up to now
Bremen pharmacologist Gerd Glaeske called for "a more intensive control network" In order to avoid quality defects, legislators must demand reliable product testing from drug distributors generics. At any time require proof of purchase and certificates for generic products in their offers.
Following the recall of Valsartan, the authorities recommended a move to drug safety in mid-July. Individuals should consult their doctor or pharmacist, which funds are affected by the recall, said the Federal Institute of Drugs and Medical Devices in Bonn. If necessary, they could then be switched to another drug containing valsartan. In no case should the medication be interrupted without consulting the doctor.
Source: n-tv.de
Source link
